Enhanced immunogenicity of peptide P277 by heat shock protein HSP65 vector carrying tandem repeats of P277 to prevent type 1 diabetes in NOD mice

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 9, 2008, Pages 541-548

  Liang, J ^a   Alhua, Z ^b   Yu, W ^a   Jingjing, L ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b JIANGSU NORMAL UNIVERSITY   (China)

Author keywords

HSP65; Immunogenicity; P277; Tandem repeat epitope; Type 1 diabetes

Indexed keywords

BCG VACCINE; HEAT SHOCK PROTEIN 65; HYBRID PROTEIN; PEPTIDE VACCINE; PROTEIN P277; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG RESEARCH; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN BINDING; TANDEM REPEAT; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES; BACTERIAL PROTEINS; BCG VACCINE; CHAPERONINS; DIABETES MELLITUS, TYPE 1; EPITOPES; FEMALE; HEAT-SHOCK PROTEINS; IMMUNOASSAY; MICE; MICE, INBRED NOD; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; VACCINES;

EID: 56049118493     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1062728     Document Type: Article

References (30)

1. Anjam CM, Villarreal-Ramos B, Pierce RJ, Demarco de Hormaeche R, MacNeill H, Ali T, Chatfield S, Capron A, Dougan G, Hormaeche CE. Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma Mansoni peptide 115-131 of the P22 glutatbione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live Aro-attenuated vaccine strain of Salmonella.J Immunol 1994; 153: 5634
2. Barrios C Lussow AR, Embden J Van, Zee R Van der, Rappuoli R, Costantino P et al. Mycobacterial heat shock proteins as carrier molecules. The use of the 70-kDa mycobacterial heat shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Cuerin priming. Eur J Immunol 1992; 22: 1365
3. Barrios C, Tougne C, Polla BS, Lambert PH, Del GC. Specificity of antibodies induced after immunization of mice with the mycobacterial heat shock protein of 65 kDa. Clin Exp Immunol 1994; 98: 224
4. Birk OS, Douek DC, Elias D, Takacs K, Dewchand H, Gur SL, Walker MD, Zee R van der, Cohen IR, Altmann DM. A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc Natl Acad Sci USA 1996; 93:1032
5. Bougneres PF et al. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin. Diabetes 1990; 39: 1264
6. Cohen IR. Peptide therapy for type 1 diabetes: the immunological homunculus and the rationale for vaccination. Diabetologia 2002; 45: 1468
7. Daneman D. Type I diabetes. Lancet 2006; 367: 847
8. Elias D, Cohen IR. Peptide therapy for diabetes in NOD mice. Lancet 1994; 343: 704
9. Elias D, Markovits D, Reshef T, Zee R Van der, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 1990; 87: 1576
10. Elias D, Reshef T, Birk OS, Zee R van der, Walker MD, Cohen IR. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci USA 1991; 88: 3088
11. Gaofu Q. Jun L, Xiuyun Z, Wentao L, Jie W, Jingjing L. Long lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants. Vaccine 2004; 22: 3187
12. Hannesdottir SG, Han X, Lund T, Singh M, Zee R van der, Roitt IM et al. Changes in the reproductive system of male mice immunized with a GnRH-analogue conjugated to mycobacterial hsp70. Reproduction 2004; 128: 365
13. Hsu C-T, Ting CY, Ting CJ, Chen TY, Lin CP, Whang-Peng J, Hwang J. Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats. Cancer Res 2000; 60: 3701
14. Jingjing α, Xue Y Agarwal N, Roque RS. Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1999; 40: 752
15. Jinshu X, Jingjing L, Duana P, Zheng Z, Ding M, Jie W, Rongyue C, Zhuoyi H, Rouel SR. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant. Vaccine 2005; 23: 4834
16. Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type I diabetes. J Clin Pathol 2003; 56: 1-10
17. Kim HD, Maxwell JA, Kong FK, Tang DC, Fukuchi K. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of A b1-6: toward safer and effective vaccines against Alzheimer's disease, Biochem. Biophys Res Commun 2005; 336: 84
18. Maron R, Sukhova G, Faria AM, Hoffmann E, Mach F, Libby P, Weiner HL. Mucosal administration of hsp65 decreases atherosclerosis and inflammation in Aortic Arch of low-density lipoprotein receptor-deficient mice. Circulation 2002; 106: 1708
19. Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res 2002; 8: 2044
20. Oscherwitz J, Zeigler ME, Loh CJ, Gribbin TE, Cease KB. The enhanced immunogenicity of a recombinant immunogen containing a tandemly repeated HIV-1T helper epitope is an intrinsic immunological property unrelated to epitope dose. Vaccine Res 1997; 6: 15
21. Palliser D, Huang Q, Hacohen N, Lamontagne SP, Guillen E, Young RA, Eisen HN. A role for Toll-like receptor 4 in dendritic cell activation and cytolytic CD8+ T cell differentiation in response to a recombinant heat shock fusion protein. J Immunol 2004; 172: 2885
22. Perraut R, Lussow AR, Gavoille S, Garrard O, Matile H, Tougne C et al. Successful primate immunization with peptides conjugated in the absence of adjuvants. Clin Ezp Immunol 1993; 93: 382
23. Romero SS, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE et al. Reduction in functional antibody activity against streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999; 29: 281
24. Silverstein J et al. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N Engl J Med 1988; 319: 599
25. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002; 2: 185
26. Suzue K, Zhou X, Eisen HN, Young RA. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci USA 1997; 94: 13146
27. Tobian AAR, Canaday, DH, Harding CV. Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells. J Immunol 2004; 173:5130
28. Tobian AAR, Harding CV, Canaday DH. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC crossprocessing and -presentation by B lymphocytes. J Immunol 2005: 174: 5209
29. Yankai Z, Rong Y, Yi H, Wentao L, Rongyue C, Ming Y, Taiming L, Jingjing L, Jie W. Ten tandem repeats of β-hCG 109-118 enhance immunogenicity and anti-tumor effects of β-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65. Biochemical and Bio-physical Research Communications 2006; 345: 1365
30. Yi H, Rong Y, Yankai Z, Wentao L, Hongxia Z, fie W, Rongyue C, Taiming L, Jingjing L. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65. Vaccine 2006; 24: 2575